Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial.
Tang W, Cao Z, Han M, Wang Z, Chen J, Sun W, Wu Y, Xiao W, Liu S, Chen E, Chen W, Wang X, Yang J, Lin J, Zhao Q, Yan Y, Xie Z, Li D, Yang Y, Liu L, Qu J, Ning G, Shi G, Xie Q.
Tang W, et al. Among authors: liu l, liu s.
BMJ. 2020 May 14;369:m1849. doi: 10.1136/bmj.m1849.
BMJ. 2020.
PMID: 32409561
Free PMC article.
Clinical Trial.